Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Richter A, Bdeir N, Graichen L, Moldenhauer AS, Dopfer-Jablonka A, Stankov MV, Simon-Loriere E, Schulz SR, Jäck HM, Čičin-Šain L, Behrens GMN, Drosten C, Hoffmann M, Pöhlmann S. Zhang L, et al. Among authors: cossmann a. Cell. 2024 Feb 1;187(3):596-608.e17. doi: 10.1016/j.cell.2023.12.025. Epub 2024 Jan 8. Cell. 2024. PMID: 38194966
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.
Odak I, Riemann L, Sandrock I, Cossmann A, Ramos GM, Hammerschmidt SI, Ritter C, Friedrichsen M, Hassan A, Dopfer-Jablonka A, Stankov MV, Weskamm LM, Addo MM, Ravens I, Willenzon S, Schimrock A, Ristenpart J, Janssen A, Barros-Martins J, Hansen G, Falk C, Behrens GMN, Förster R. Odak I, et al. Among authors: cossmann a. EBioMedicine. 2024 Jan;99:104947. doi: 10.1016/j.ebiom.2023.104947. Epub 2023 Dec 30. EBioMedicine. 2024. PMID: 38160529 Free PMC article.
Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.
Stankov MV, Hoffmann M, Gutierrez Jauregui R, Cossmann A, Morillas Ramos G, Graalmann T, Winter EJ, Friedrichsen M, Ravens I, Ilievska T, Ristenpart J, Schimrock A, Willenzon S, Ahrenstorf G, Witte T, Förster R, Kempf A, Pöhlmann S, Hammerschmidt SI, Dopfer-Jablonka A, Behrens GMN. Stankov MV, et al. Among authors: cossmann a. Lancet Infect Dis. 2024 Jan;24(1):e1-e3. doi: 10.1016/S1473-3099(23)00690-4. Epub 2023 Nov 20. Lancet Infect Dis. 2024. PMID: 37995739 No abstract available.
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3.
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz SR, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Zhang L, et al. Among authors: cossmann a. Lancet Infect Dis. 2023 Oct;23(10):e391-e392. doi: 10.1016/S1473-3099(23)00547-9. Epub 2023 Sep 13. Lancet Infect Dis. 2023. PMID: 37716358 No abstract available.
Migrant healthcare workers during COVID-19: bringing an intersectional health system-related approach into pandemic protection. A German case study.
Kuhlmann E, Ungureanu MI, Behrens GMN, Cossmann A, Fehr LM, Klawitter S, Mikuteit M, Müller F, Thilo N, Brînzac MG, Dopfer-Jablonka A. Kuhlmann E, et al. Among authors: cossmann a. Front Public Health. 2023 Jul 18;11:1152862. doi: 10.3389/fpubh.2023.1152862. eCollection 2023. Front Public Health. 2023. PMID: 37533524 Free PMC article.
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.
Barros-Martins J, Hammerschmidt SI, Morillas Ramos G, Cossmann A, Hetzel L, Odak I, Köhler M, Stankov MV, Ritter C, Friedrichsen M, Ravens I, Schimrock A, Ristenpart J, Janssen A, Willenzon S, Bernhardt G, Lichtinghagen R, Bošnjak B, Behrens GMN, Förster R. Barros-Martins J, et al. Among authors: cossmann a. Front Immunol. 2023 May 5;14:1166589. doi: 10.3389/fimmu.2023.1166589. eCollection 2023. Front Immunol. 2023. PMID: 37215123 Free PMC article.
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage.
Nehlmeier I, Kempf A, Arora P, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz SR, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Nehlmeier I, et al. Among authors: cossmann a. Cell Mol Immunol. 2023 Aug;20(8):969-971. doi: 10.1038/s41423-023-01030-z. Epub 2023 May 8. Cell Mol Immunol. 2023. PMID: 37156807 Free PMC article. No abstract available.
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5.
Hoffmann M, Arora P, Nehlmeier I, Kempf A, Cossmann A, Schulz SR, Morillas Ramos G, Manthey LA, Jäck HM, Behrens GMN, Pöhlmann S. Hoffmann M, et al. Among authors: cossmann a. Cell Mol Immunol. 2023 Apr;20(4):419-422. doi: 10.1038/s41423-023-00988-0. Epub 2023 Mar 3. Cell Mol Immunol. 2023. PMID: 36869193 Free PMC article. No abstract available.
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage.
Arora P, Cossmann A, Schulz SR, Ramos GM, Stankov MV, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Arora P, et al. Among authors: cossmann a. Lancet Infect Dis. 2023 Feb;23(2):147-148. doi: 10.1016/S1473-3099(22)00831-3. Epub 2023 Jan 5. Lancet Infect Dis. 2023. PMID: 36620969 Free PMC article. No abstract available.
43 results